Wellamo 5 Tablet contains Amlodipine 5 mg, a calcium channel blocker used primarily for the management of hypertension and angina pectoris. Amlodipine works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle cells, leading to vasodilation and reduced peripheral vascular resistance, which consequently lowers blood pressure and decreases myocardial oxygen demand. Wellamo 5 is indicated for the treatment of essential hypertension, helping to prevent complications such as stroke, myocardial infarction, and renal impairment. Additionally, it is effective in the management of chronic stable angina and vasospastic angina by improving exercise tolerance and reducing the frequency and severity of anginal attacks. The medication is typically administered once daily, with or without food, and dosage adjustments may be necessary based on patient response and tolerability. Common adverse effects include peripheral edema, headache, dizziness, and fatigue, which are generally mild and transient. Caution is advised in patients with severe hypotension, aortic stenosis, or heart failure. Wellamo 5 should be used under medical supervision, with regular monitoring of blood pressure and clinical status to ensure optimal therapeutic outcomes.